Page last updated: 2024-08-23

daunorubicin and gallium

daunorubicin has been researched along with gallium in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Carter, SK1
Elliott, RL; Head, JF; Wang, F1
Abodo, LO; Baas, J; Frias, C; Frias, J; Jakupec, MA; Keppler, BK; Prokop, A; Wilke, NL1

Reviews

1 review(s) available for daunorubicin and gallium

ArticleYear
New cytotoxic drugs for breast cancer and their clinical evaluation.
    European journal of cancer, 1980, Volume: Suppl 1

    Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin

1980

Trials

1 trial(s) available for daunorubicin and gallium

ArticleYear
New cytotoxic drugs for breast cancer and their clinical evaluation.
    European journal of cancer, 1980, Volume: Suppl 1

    Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin

1980

Other Studies

2 other study(ies) available for daunorubicin and gallium

ArticleYear
Antineoplastic drugs that interfere with iron metabolism in cancer cells.
    Advances in enzyme regulation, 1997, Volume: 37

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cisplatin; Clinical Trials as Topic; Daunorubicin; Deferoxamine; Female; Gallium; Humans; Indium; Iron; Rats; Transferrin; Tumor Cells, Cultured

1997
The gallium complex KP46 sensitizes resistant leukemia cells and overcomes Bcl-2-induced multidrug resistance in lymphoma cells via upregulation of Harakiri and downregulation of XIAP in vitro.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 156

    Topics: Apoptosis; Daunorubicin; Down-Regulation; Drug Resistance, Multiple; Gallium; Humans; Leukemia; Lymphoma; Organometallic Compounds; Up-Regulation; X-Linked Inhibitor of Apoptosis Protein

2022